Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018

SELL
$39.82 - $57.53 $3.42 Million - $4.95 Million
-85,984 Closed
0 $0
Q4 2017

Feb 13, 2018

SELL
$46.49 - $60.51 $55,602 - $72,369
-1,196 Reduced 1.37%
85,984 $45.2 Million
Q3 2017

Nov 06, 2017

BUY
$37.05 - $47.12 $3.23 Million - $4.11 Million
87,180
87,180 $4.11 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.96B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Crosspoint Capital Strategies, LLC Portfolio

Follow Crosspoint Capital Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crosspoint Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crosspoint Capital Strategies, LLC with notifications on news.